National Peroxide Ltd (NPL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by National Peroxide Ltd on NSE and BSE, with an AI summary of each filing.
Please find attached herewith details regarding Resignation of Director of the Company.
Change in Management · 01 Oct 2026, 10:53 pm
National Peroxide Appoints Vinay Jayade as CEO and Whole-Time Director National Peroxide Limited approved the appointment of Vinay Divakar Jayade as Chief Executive Officer and Whole-Time Director for a five-year term starting 3rd Nov'26, subject to shareholder approval. Jayade assumes the role of CEO Designate on 1st Oct'26 to oversee a smooth leadership transition. He succeeds Rajiv Arora, who resigned due to personal reasons and will step down on 2nd Nov'26. Jayade brings over 34 years of specialty chemicals experience, previously serving as JV President at Cabot Sanmar and MD at ASK Chemicals India.
Pleased find attached herewith details Change in Director and Key Managerial Personnel of the Company.
Change in Management · 01 Oct 2026, 10:51 pm
National Peroxide Appoints Vinay Divakar Jayade as CEO and Whole-Time Director National Peroxide Limited's Board approved the appointment of Mr. Vinay Divakar Jayade as Chief Executive Officer and Whole-Time Director for a five-year term, effective 3rd Nov'26, subject to shareholder approval. Mr. Jayade joined as CEO & WTD (Designate) on 1st Oct'26 to oversee transition activities. He succeeds Mr. Rajiv Arora, who resigned due to personal reasons and will step down from his role at the close of business hours on 2nd Nov'26. Mr. Jayade brings over 34 years of leadership experience across specialty chemicals and materials.
Please find attached herewith Outcome of Board Meeting held on October 01, 2026.
Others (Uncategorized) · 01 Oct 2026, 10:48 pm
National Peroxide Appoints Vinay Divakar Jayade as CEO and Whole-Time Director National Peroxide Limited's Board approved the appointment of Vinay Divakar Jayade as Chief Executive Officer and Whole-Time Director for a five-year term, effective 3rd Nov'26, subject to shareholder approval. Jayade joins as CEO & WTD (Designate) on 1st Oct'26 to ensure an orderly leadership transition. He succeeds Rajiv Arora, who resigned from his CEO and Director roles due to personal reasons, stepping down at the close of business hours on 2nd Nov'26. Jayade brings over 34 years of specialty chemicals and materials industry leadership experience.
Please find attached herewith Scrutinizers'' Report and voting Results as required under Listing Regulations.
Annual General Meeting · 30 Sept 2026, 2:05 am
National Peroxide Shareholders Approve FY26 Dividend and Key AGM Resolutions National Peroxide Limited announced the approval of all resolutions at its 6th AGM held on 29th Sep'26 with requisite majority. Shareholders approved the adoption of FY26 audited financial statements, the declaration of a final dividend of Rs. 7.00 per equity share (70% on face value of Rs. 10), the reappointment of Mr. Ness N. Wadia as Director retiring by rotation, the reappointment of M/s. Kalyaniwalla & Mistry LLP as statutory auditors, and the ratification of cost auditor remuneration for FY27. Total voter turnout stood at 70.85%.
Please find enclosed herewith the Proceedings of the 6th Annual General Meeting of the Company.
Annual General Meeting · 30 Sept 2026, 1:49 am
Please find enclosed herewith the outcome of the 6th Annual General Meeting of the Company held on Tuesday, September 29, 2026, at 11:00 AM through Video Conferencing/ Other Audio Video Visual Means.
Annual General Meeting · 30 Sept 2026, 1:40 am
Please find enclosed herewith communication sent to shareholders regarding TDS on Dividend for FY 2025-26.
Dividend · 05 Sept 2026, 12:25 am
National Peroxide Details FY26 Dividend TDS Framework and Submission Timelines National Peroxide recommended a dividend of Rs. 7.00 per equity share (70% on face value Rs. 10) for FY'25-26, subject to AGM approval on 29th Sep'26. The record date for dividend eligibility is 22nd Sep'26, with payouts scheduled after 29th Sep'26. Dividend distribution is subject to TDS at 10% for residents with valid PAN (20% without PAN or if unlinked to Aadhaar) and 20% plus applicable surcharge/cess for FIIs/FPIs and non-residents, treaty benefits applicable. Tax exemption documentation must be submitted by 22nd Sep'26.
Please find attached herewith communication sent to the Shareholders pertaining to Notice of 6th Annual General Meeting along with Annual Report for FY 25-26
Annual General Meeting · 04 Sept 2026, 1:35 am
Please find attached herewith Notice of 6th Annual General Meeting of the Company along with Annual Report for FY 2025-26.
Annual General Meeting · 04 Sept 2026, 1:33 am
Please find attached herewith Annual Report of the Company for FY 2025-26 along with Notice of 6th Annual General meeting.
Others (Uncategorized) · 04 Sept 2026, 1:28 am
The Board of Directors, at its meeting held on April 30, 2026, had recommend the final dividend 70%, being Rs. 7 per equity share of Rs. 10 each, for the financial year ended March 31, ....
Dividend · 12 Aug 2026, 7:01 pm
Please find attached herewith details of Annual general Meeting of the Company.
Annual General Meeting · 12 Aug 2026, 6:53 pm
The Board has in its meeting held August 12, 2026, has recommended the reappointment of the Statutory Auditor of the Company.
Change in Auditor · 12 Aug 2026, 6:51 pm
National Peroxide Restates FY26 Profits Downward After ERP Error National Peroxide has retrospectively restated its financials for the quarter ended Dec 31, '25 and the year ended Mar 31, '26, following the discovery of an ERP accounting error. The error understated raw material costs by ₹694.63 lakh, resulting in a significant profit overstatement. Consequently, FY26 PAT was revised down to ₹582.42 lakh from ₹1,103.71 lakh, with FY26 EPS falling to ₹10.13 from ₹19.20. The Board also approved unaudited Q1'27 results, showing PAT of ₹660.89 lakh. The FY26 dividend recommendation of ₹7/share remains unchanged.
Please find attached herewith unaudited financial results for quarter ended June 30, 2026
Financial Result · 12 Aug 2026, 6:48 pm
National Peroxide Restates FY26 Results; Q1FY27 PAT Rises 641% YoY National Peroxide has restated its financial results for Q4FY26 and FY26 due to an accounting error that understated raw material costs by ₹694.63 lakhs. For Q1FY27, the company reported a Profit After Tax of ₹660.89 lakhs, up 641% YoY, on revenue of ₹9,606.77 lakhs (+44.1% YoY). EBITDA for the quarter stood at ₹1,436.80 lakhs. On Aug 12, '26, the board approved the unaudited Q1FY27 results and the revised FY26 results, which received an unmodified opinion from auditors.
Please find attached herewith Revised Financial results for the quarter and year ended March 31, 2026
Financial Result · 12 Aug 2026, 6:46 pm
National Peroxide Restates FY26 Results Following Accounting Error Discovery National Peroxide has restated its financial results for Q4 FY26 and the full year ended 31 Mar'26. This follows the discovery of an ERP system error that understated raw material costs by ₹694.63 lakh, consequently overstating profit. The restatement corrects this error retrospectively. Revised FY26 PAT now stands at ₹582.42 lakh, a significant revision. Q1 FY27 (ended 30 Jun'26) results show a PAT of ₹660.89 lakh. A final dividend of ₹7/share for FY26 remains unchanged, with a record date of 22 Sep'26.
This is to inform you that the Board of Directors of the Company at their meeting held today i.e., on Wednesday August 12, 2026, have inter-alia, considered and approved the following: ....
Outcome · 12 Aug 2026, 6:39 pm
National Peroxide Restates FY26 Earnings Due to Accounting Error National Peroxide has restated its financial results for Q4 FY26 and the full year ended Mar '26, following the discovery of an ERP accounting error. The error led to an understatement of raw material costs by ₹694.63 lakhs and a consequent overstatement of profit. For FY26, the company now reports a net profit of ₹582.42 lakhs, a sharp reversal from the previously reported ₹1,103.71 lakhs. The board maintained its final dividend of ₹7/share. For Q1 FY27, net profit stood at ₹660.89 lakhs on revenue of ₹9,606.77 lakhs.
This is to inform you that the Board of Directors of the Company at their meeting held today i.e., on Wednesday August 12, 2026, have inter-alia, considered and approved the following: ....
Outcome · 12 Aug 2026, 6:38 pm
National Peroxide Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 9,607 (+44.1% YoY | +12.1% QoQ) ■ EBITDA: 1,224 (+153.8% YoY | -17.7% QoQ) ■ EBITDA Margin (%): 12.7 (+551 bps YoY | -462 bps QoQ) ■ PAT: 661 (+642.3% YoY | -28.4% QoQ) ■ EPS (INR): 11.5 (+641.9% YoY | -28.4% QoQ)
National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve i. Revised Audited Financial ....
Intimation · 12 Aug 2026, 5:30 am
National Peroxide Ltd Board Meeting on 12 Aug'26 for Q1FY27 Results National Peroxide Ltd (BSE: 544205) has scheduled a Board of Directors meeting on 12 Aug'26. Key agenda items include the approval of the un-audited financial results for the quarter ended 30 Jun'26 (Q1FY27). Additionally, the board will consider and approve revised audited financial results and statements for the quarter and financial year ended 31 Mar'26.
The Board Meeting to be held on 03/08/2026 Stands Cancelled.
Rescheduled / Cancelled · 02 Aug 2026, 8:58 pm
National Peroxide Defers Board Meeting for Q1 Results National Peroxide Ltd has deferred its Board Meeting originally scheduled for 03 Aug '26. The meeting was intended to approve the unaudited financial results for the quarter ended 30 Jun '26. The company cited "unavoidable circumstances" for the deferment and will announce a new date in due course. Consequently, the trading window, which closed on 01 Jul '26, will remain shut for designated persons until 48 hours after the rescheduled meeting's results are declared.
National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Intimation · 12 Aug 2026, 5:30 am
National Peroxide Board Meeting on 3rd Aug'26 for Q1 Results National Peroxide Limited (BSE: 544205) announced its Board of Directors will meet on Mon, 3rd Aug'26. The agenda includes consideration and approval of the company's Unaudited Financial Results for the first quarter (Q1) ended 30th Jun'26. This meeting is crucial for assessing the company's performance at the start of the financial year.
Please find attached resignation of Chief Information Officer of the Company.
Change in Management · 15 Jul 2026, 11:41 pm
National Peroxide CIO Resigns, Citing Personal Reasons National Peroxide Limited (BSE: 544205) announced the resignation of its Chief Information Officer, Mr. Rajeev Pradhan, effective 15th Jul'26. The company stated the departure is due to personal reasons. This change in senior management was disclosed per SEBI listing regulations. The announcement confirms there are no other material details associated with the resignation.
Please find attached Financial Results.
Financial Result · 01 May 2026, 3:14 am
National Peroxide Limited - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 8568 (+16.3% YoY | +24.0% QoQ) ■ EBITDA: 1488 (Loss to Profit YoY | +113.1% QoQ) ■ EBITDA Margin (%): 17.4 (Loss to Profit YoY | +726 bps QoQ) ■ PAT: 793 (Loss to Profit YoY | +332.7% QoQ) ■ EPS (INR): 13.8 (Loss to Profit YoY | +332.6% QoQ)
The Company hereby informs that The Board of Directors in its meeting held on April 30, 2026, has approved the appointment of Chief Financial Officer of the Company
Change in Management · 01 May 2026, 3:07 am
National Peroxide Reports FY26 Results, Recommends Dividend & Appoints New CFO National Peroxide reported Q4FY26 PAT of ₹7.93 Cr, a significant turnaround from a ₹6.49 Cr loss YoY. Full-year FY26 PAT stood at ₹11.04 Cr versus a loss of ₹2.25 Cr in FY25, with EPS at ₹19.20. The Board recommended a final dividend of ₹7 per share (70%). Additionally, the company announced a key management change: Interim CFO Amit Goriwale will step down effective 31 May'26, and Chirag Kothari has been appointed as the new CFO & CRO, effective 01 Jun'26.
The Company hereby informs the Exchange that Mr. Amit Goriwale has step down from the position of Interim Chief Financial Officer of the Company from close of business hours May 31, 2026
Change in Management · 01 May 2026, 3:01 am
National Peroxide FY26 Results: Board Approves Dividend and Appoints New CFO National Peroxide reported Q4FY26 PAT of ₹792.86 lakh, a significant turnaround from a loss of ₹649.01 lakh YoY, driven by higher revenue of ₹8,568.29 lakh. For FY26, PAT stood at ₹1,103.71 lakh versus a loss of ₹224.64 lakh in FY25, with EPS at ₹19.20. The Board recommended a final dividend of ₹7 per share. Additionally, Mr. Chirag Kothari has been appointed as CFO & CRO effective Jun 01, '26, following the resignation of Interim CFO Mr. Amit Goriwale, effective May 31, '26.
Please find enclosed Board Meeting Outcome contains details of Dividend
Dividend · 01 May 2026, 2:57 am
FY26 Results: Dividend of Rs 7 Declared, New CFO Appointed National Peroxide reported Q4FY26 PAT of Rs 792.86 lakh versus a loss of Rs 649.01 lakh YoY. FY26 PAT stood at Rs 1,103.71 lakh compared to a loss of Rs 224.64 lakh in FY25. The Board recommended a final dividend of Rs 7 per share (70%) for FY26, subject to shareholder approval. Concurrently, the company announced a key management change: Amit Goriwale will step down as Interim CFO on May 31, '26, with Chirag Kothari appointed as the new CFO & CRO effective Jun 01, '26.